These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24629028)

  • 1. Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy.
    Harritshøj LH; Nielsen C; Ullum H; Hansen MB; Julian HO
    Acta Ophthalmol; 2014 Dec; 92(8):783-6. PubMed ID: 24629028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye.
    Versura P; Profazio V; Buzzi M; Stancari A; Arpinati M; Malavolta N; Campos EC
    Cornea; 2013 Apr; 32(4):412-8. PubMed ID: 22955120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment.
    Jirsova K; Brejchova K; Krabcova I; Filipec M; Al Fakih A; Palos M; Vesela V
    Curr Eye Res; 2014 Jan; 39(1):21-30. PubMed ID: 24074049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies.
    Semeraro F; Forbice E; Braga O; Bova A; Di Salvatore A; Azzolini C
    Biomed Res Int; 2014; 2014():826970. PubMed ID: 25136628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies.
    Poon AC; Geerling G; Dart JK; Fraenkel GE; Daniels JT
    Br J Ophthalmol; 2001 Oct; 85(10):1188-97. PubMed ID: 11567963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of serum eye drops after storage of 6 months.
    Fischer KR; Opitz A; Böeck M; Geerling G
    Cornea; 2012 Nov; 31(11):1313-8. PubMed ID: 22955119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Chiang CC; Lin JM; Chen WL; Tsai YY
    Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery.
    Lekhanont K; Jongkhajornpong P; Choubtum L; Chuckpaiwong V
    Biomed Res Int; 2013; 2013():521315. PubMed ID: 23984378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous serum utilization in patients with lacrimal hyposecretion and persistent epithelial defects of cornea--clinical study].
    Nistor M; Nistor C
    Oftalmologia; 2005; 49(3):30-3. PubMed ID: 16408672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Platelet-rich Plasma Eye Drops in the Treatment of Recurrent Corneal Erosions.
    Lee JH; Kim MJ; Ha SW; Kim HK
    Korean J Ophthalmol; 2016 Apr; 30(2):101-7. PubMed ID: 27051257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous serum eye drops for the treatment of persistent corneal epithelial defects.
    Arain MA; Dar AJ; Adeeb L
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):737-9. PubMed ID: 24112261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].
    Geerling G; Hartwig D
    Ophthalmologe; 2002 Dec; 99(12):949-59. PubMed ID: 12478384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood derived eye drops for the treatment of cornea and ocular surface diseases.
    Giannaccare G; Versura P; Buzzi M; Primavera L; Pellegrini M; Campos EC
    Transfus Apher Sci; 2017 Aug; 56(4):595-604. PubMed ID: 28844373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of application systems for autologous serum eye drops.
    Spaniol K; Koerschgen L; Sander O; Koegler G; Geerling G
    Curr Eye Res; 2014 Jun; 39(6):571-9. PubMed ID: 24400979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous serum eye drops for ocular surface disorders.
    Geerling G; Maclennan S; Hartwig D
    Br J Ophthalmol; 2004 Nov; 88(11):1467-74. PubMed ID: 15489495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye.
    Jacobi C; Kruse FE; Cursiefen C
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):598-603. PubMed ID: 22813209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.
    Iester M; Orsoni GJ; Gamba G; Taffara M; Mangiafico P; Giuffrida S; Rolando M
    Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects.
    Schrader S; Wedel T; Moll R; Geerling G
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1345-9. PubMed ID: 16544115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a standardised method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian University Hospital: Some methodological aspects and clinical considerations.
    Espinosa A; Hjorth-Hansen H; Aasly K; Teigum I; Sivertsen G; Seghatchian J
    Transfus Apher Sci; 2015 Aug; 53(1):88-91. PubMed ID: 26027793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.